AKRO
Akero Therapeutics Inc
Price:  
30.35 
USD
Volume:  
217,844.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKRO Probability of Bankruptcy

The Probability of Bankruptcy of Akero Therapeutics Inc (AKRO) is 7.20% . This number represents the probability that AKRO will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating AKRO's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

AKRO - ESG ratings

ESG ratings are directly linked to the cost of capital and AKRO's ability to raise funding, both of which can significantly affect the probability of Akero Therapeutics Inc going bankrupt.

ESG Score 49.06
Environment Score 45.94
Social Score 56.03
Governance Score 45.20
Returns
Historical Returns (5 day) -0.91%
Historical Returns (MTD) -4.55%
Historical Returns (YTD) 31.22%
Historical Returns (13 week) 19.04%
Historical Returns (26 week) 43.65%
Historical Returns (52 week) 57.53%
Efficiency
Asset Turnover
Receiveable Turnover
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA) -29.89
Return on Equity (ROE) -32.52
Return on Investments (ROI) -31.13
Price Metrics
Market Cap (M) 2,118.43
Enterprise Value (M)
52 Week High 37.00
52 Week Low 15.35
Beta 1.47
Average Volume (10 day) 0.50
Average Volume (3 month) 0.54
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS -3.75
Revenue CAGR (5 year)
Risk
Current Ratio 17.25
Quick Ratio 16.57